These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Hosford DA; Wang Y Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845 [TBL] [Abstract][Full Text] [Related]
86. Rethinking the treatment paradigm for bipolar depression: the importance of long-term management. Baldassano CF; Ballas CA; O'Reardon JP CNS Spectr; 2004 Sep; 9(9 Suppl 9):11-8. PubMed ID: 15361807 [TBL] [Abstract][Full Text] [Related]
87. Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity. Zand L; McKian KP; Qian Q Am J Med; 2010 Apr; 123(4):367-73. PubMed ID: 20362757 [TBL] [Abstract][Full Text] [Related]
88. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Lhatoo SD; Wong IC; Polizzi G; Sander JW Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218 [TBL] [Abstract][Full Text] [Related]
89. Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy. Striano P; Coppola A; Madia F; Pezzella M; Ciampa C; Zara F; Striano S Epilepsia; 2007 Oct; 48(10):1995-8. PubMed ID: 17645541 [TBL] [Abstract][Full Text] [Related]
90. The efficacy of gabapentin in migraine prophylaxis: an observational open label study. Vuković V; Lovrencić-Huzjan A; Bosnar-Puretić M; Demarin V Acta Clin Croat; 2009 Jun; 48(2):145-51. PubMed ID: 19928412 [TBL] [Abstract][Full Text] [Related]
91. Are antiepileptic drugs used in the treatment of migraine associated with an increased risk of suicidality? Kanner AM Curr Pain Headache Rep; 2011 Jun; 15(3):164-9. PubMed ID: 21479999 [TBL] [Abstract][Full Text] [Related]
92. Novel anticonvulsants: a new generation of mood stabilizers? Ghaemi SN; Gaughan S Harv Rev Psychiatry; 2000; 8(1):1-7. PubMed ID: 10824292 [TBL] [Abstract][Full Text] [Related]
93. Gabapentin-induced rhabdomyolysis in a patient with diabetic neuropathy. Bilgir O; Calan M; Bilgir F; Kebapçilar L; Yüksel A; Yildiz Y; Sari I Intern Med; 2009; 48(12):1085-7. PubMed ID: 19525604 [TBL] [Abstract][Full Text] [Related]
94. Interchangeability of gabapentin generic formulations in the Netherlands: a comparative bioavailability study. Yu Y; Teerenstra S; Vanmolkot F; Neef C; Burger D; Maliepaard M Clin Pharmacol Ther; 2013 Oct; 94(4):519-24. PubMed ID: 23708746 [TBL] [Abstract][Full Text] [Related]
95. Pregabalin: new drug. Very similar to gabapentin. Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976 [TBL] [Abstract][Full Text] [Related]
96. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Kuzniecky R; Ho S; Pan J; Martin R; Gilliam F; Faught E; Hetherington H Neurology; 2002 Feb; 58(3):368-72. PubMed ID: 11839834 [TBL] [Abstract][Full Text] [Related]
99. Plasma concentration of topiramate correlates with cerebrospinal fluid concentration. Christensen J; Højskov CS; Dam M; Poulsen JH Ther Drug Monit; 2001 Oct; 23(5):529-35. PubMed ID: 11591899 [TBL] [Abstract][Full Text] [Related]
100. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Bockbrader HN; Wesche D; Miller R; Chapel S; Janiczek N; Burger P Clin Pharmacokinet; 2010 Oct; 49(10):661-9. PubMed ID: 20818832 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]